Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Is the Mumps Vaccine Becoming Less Effective?Autism Now Diagnosed in 1 in Every 44 Children, CDC SaysNearly 7% of U.S. Kids Have Had a Head Injury or ConcussionAre Your Holiday Gifts on the 'Noisy Toy List'?Many Kids, Teens Think Girls Don't Care About Computer ScienceMost Parents Say Their Kids Aren't Thankful Enough: PollPandemic Curbed Kids' Efforts to Lose Excess WeightClimate Change May Not Increase Allergies in Kids With Asthma: StudyNearly 10% of Younger Kids Have Gotten First COVID Vaccine DoseAHA News: Family-Based Programs Targeting Childhood Obesity Can Be Good for Parents, TooCases of Children's Severe COVID-Linked Illness Were Worse in Second WaveFace Masks Don't Hide Emotions From Kids: StudyAdult 'Picky Eaters' on What Parents Did Right and WrongWHO, CDC Warn of Measles Threat After 22 Million Infants Miss Shots During PandemicWealthier Parents More Likely to Get COVID Vaccines for Young Kids: PollNearly 900,000 U.S. Kids Under 12 Have Gotten Their First COVID ShotNo Evidence Violent Video Games Lead to Real Violence: StudyDo Your Kids Really Need Cough & Cold Meds?AHA News: What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-OldsFor Kids Afraid of Needles, These Tips May Help Ease COVID ShotsCDC Signs Off on Pfizer Vaccine for Younger KidsWe've Been Here Before: How Polio Vaccine Rollout Saved Millions of Young LivesVaccinations for Kids Will Be in Full Swing by Nov. 8, White House SaysFDA Approves Pfizer COVID Vaccine for Kids 5-11Attorneys General Warn About Pot Products That Look Like Halloween TreatsCDC Lowers Threshold for Lead Poisoning in Youngest KidsFDA Advisors Approve Emergency Use of Pfizer COVID Vaccine in Kids 5 to 11Moderna Says Its COVID Vaccine Works Well in Children Aged 6 to 11Pediatricians Offer Advice on Keeping Trick-or-Treaters SafeThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenWhite House Announces COVID Vaccination Plan for Young KidsMany Parents Worry That Kids Fell Behind in Schooling During PandemicNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsU.S. Pediatricians, Psychiatrists Declare 'Emergency' in Child Mental HealthState Spending on Poverty Really Pays Off for Kids: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollKids Can Carry High, Infectious Levels of COVID CoronavirusBystanders Can Make the Difference for a Drowning ChildAs COVID Cases Drop, Fauci Tells Families to Enjoy HalloweenGolf Cart Injuries Keep Rising Among U.S. KidsStudy Confirms Rise in Child Abuse During COVID PandemicSocial Distancing Kept Kids From Getting Flu, RSVPfizer Seeks FDA Emergency Approval for COVID Vaccine in Younger KidsCould an App Help Kids With Severe Ear Condition Avoid Surgery?Kids With Food Allergies Are Often Targets for BulliesAs Kids Turned to Screens During Pandemic, Their Mental Health SufferedRacial Disparities Persist With Childhood Cancers
Links
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Moderna Says Its COVID Vaccine Works Well in Children Aged 6 to 11

HealthDay News
by Robert Preidt
Updated: Oct 25th 2021

new article illustration

MONDAY, Oct. 25, 2021 (HealthDay News) -- Moderna announced Monday that its COVID-19 vaccine safely triggers a strong immune response in children aged 6 to 11.

Company data shows that a month after receiving both doses of the vaccine, children's antibody levels were 1.5 times higher than those in young adults. The company did not release the full data on the shots and the results have not been published in a peer-reviewed journal.

"We are encouraged by the immunogenicity and safety profile of mRNA-1273 [Moderna's vaccine] in children aged 6 to under 12 years and are pleased that the study met its primary immunogenicity endpoints," said Stéphane Bancel, chief executive officer of Moderna. "We look forward to filing with regulators globally and remain committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all ages."

The trial included more than 4,700 children who received two shots of the vaccine 28 days apart. Each shot contained 50 micrograms of vaccine, half the adult dose. Most side effects were mild or moderate, and the most common were fatigue, headache, fever and pain at the injection site, according to Moderna.

The vaccine's safety will continue to be reviewed by an independent monitoring committee for 12 months after the second dose, The New York Times reported.

Moderna is still recruiting children aged 2 through 5, and 6 months to under 2 years for trials of the vaccine in those age groups. So far, the company has enrolled about 5,700 children in the United States and Canada in that trial.

On Tuesday, a U.S. Food and Drug Administration advisory committee is scheduled to weigh the use of the Pfizer coronavirus vaccine in children aged 5 through 11.

In June, Moderna submitted trial results for use of its COVID-19 vaccine in youth aged 12 through 17, but the FDA has not yet announced a decision for that age group, the Times reported.

Some research indicates that the Moderna vaccine may increase the risk of a rare side effect of heart muscle inflammation (myocarditis) in boys and young men. In July, the FDA asked both Pfizer and Moderna to increase the size of their trials to try to detect less common side effects, the Times reported.

More information

Visit the U.S. Food and Drug Administration for more on COVID vaccines.

SOURCES: Moderna, news release, Oct. 25, 2021; The New York Times




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net